| 000 | 00754 a2200205 4500 | ||
|---|---|---|---|
| 005 | 20250517080902.0 | ||
| 264 | 0 | _c20160212 | |
| 008 | 201602s 0 0 eng d | ||
| 022 | _a2056-5933 | ||
| 024 | 7 |
_a10.1136/rmdopen-2015-000154 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLai, Zhihong | |
| 245 | 0 | 0 |
_aKey design considerations on comparative clinical efficacy studies for biosimilars: adalimumab as an example. _h[electronic resource] |
| 260 |
_bRMD open _c2016 |
||
| 300 |
_ae000154 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 700 | 1 | _aLa Noce, Anna | |
| 773 | 0 |
_tRMD open _gvol. 2 _gno. 1 _gp. e000154 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/rmdopen-2015-000154 _zAvailable from publisher's website |
| 999 |
_c25726653 _d25726653 |
||